Skip to main content
. 2023 Jun 27;24:192. doi: 10.1186/s12882-023-03186-2

Table 1.

The IVW values for MR. IVs in the MR study means that IVs that actually participate in the MR study, after harmonising the information from exposure and outcome

Diseases IVs in the MR study Factors p.value 95%LCI OR/Beta 95%UCI
DN 3 25(OH)D 0.987 0.269 1.011 3.793
T1DN(early) 3 25(OH)D 0.726 0.030 0.587 11.458
T1DN(later) 3 25(OH)D 0.752 0.114 1.517 20.208
T2DN(early) 3 25(OH)D 0.109 0.001 0.039 2.075
T2DN(later) 3 25(OH)D 0.435 0.389 1.870 8.990
Prostate cancer 3 25(OH)D 0.087 0.999 1.008 1.017
Breast cancer 3 25(OH)D 0.092 0.996 1.027 1.060
Multiple sclerosis 2 25(OH)D 0.005 0.151 0.327 0.709
CKD(eGFRcyea) 3 25(OH)D 0.005 -0.090 -0.053 -0.016
DM(eGFRcyea) 3 25(OH)D 0.971 -0.355 0.007 0.369
DM(UACR) 3 25(OH)D 0.751 -0.961 0.186 1.333
DN 9 BMI 0.034 1.007 1.102 1.206
T1DN(early) 9 BMI 0.700 0.880 0.979 1.090
T1DN(later) 9 BMI 0.001 1.117 1.322 1.564
T2DN(early) 8 BMI 0.661 0.832 1.054 1.336
T2DN(later) 8 BMI 0.142 0.946 1.180 1.473
CKD(eGFRcyea) 8 BMI 0.131 -0.010 -0.004 0.001
DM(eGFRcyea) 8 BMI 0.730 -0.017 0.004 0.024
DM(UACR) 8 BMI 0.011 0.034 0.149 0.264
CKD(eGFRcyea) 1 KIM-1 0.016 -0.009 -0.005 -0.001
DM(eGFRcyea) 1 KIM-1 0.043 -0.032 -0.016 -0.001
DM(UACR) 1 KIM-1 0.652 -0.150 -0.028 0.094
DN 1 KIM-1 0.125 0.815 0.914 1.025
D1N(early) 1 KIM-1 0.374 0.753 0.915 1.113
D1N(later) 1 KIM-1 0.123 0.950 1.209 1.539
D2N(early) 1 KIM-1 0.227 0.911 1.160 1.477
D2N(later) 1 KIM-1 0.352 0.847 1.162 1.593

95%LCI The lower limit of 95% CI, 95%UCI The upper limit of 95% CI, T1DN Type 1 diabetic neuropathy, T2DN Type 2 diabetic neuropathy, DM Diabetic mellitus, DN Diabetic nephropathy, CKD Chronic kidney disease